Eupraxia Pharmaceuticals

US · EPRX #3732 by market cap

7.52 -0.26 -3.34%

Live - 5344 symbols - heartbeat 357s ago · 2026-10-08 09:55

Pre-market 8.05 +3.47%

After-hours 7.78 0.00%

Market cap: 496.87M
P/E (TTM): -7.37
P/B: 4.88
EPS: -1.03
Div yield: 0.00%
52W pos: 56%

Reader sentiment Are you bullish or bearish on EPRX?

Anonymous reader poll. Unscientific, not investment advice.

About Eupraxia Pharmaceuticals

Eupraxia Pharmaceuticals, Inc. operates as a drug delivery technology company in Canada. It delivers drugs into body compartments, such as the joint without any of the common issues with body compartment injections, such as systemic exposure. The firm focuses on arthritis, diabetic macular edema, and chronic pain programs. The company was founded by James A. Helliwell, John Salvatore Montalbano and Amanda Malone on May 12, 2011 and is headquartered in Victoria, Canada.

Founded: 2011
CEO: Dr. James A. Helliwell, M.D.
Employees: 49
Headquarters: Victoria, British Columbia, Canada
Fiscal year end: 12-31
Website: eupraxiapharma.com

Company profile

Exchange: US
Symbol: EPRX
Market-cap rank: #3732
Market cap: 496.87M
Float cap: 419.88M
Shares out: 66.07M
Float shares: 55.84M

Sectors & themes

Biotechnology Stocks tradable only on moomoo

Browse all sectors & themes

Quote time 2026-10-08 09:55:38 · For reference only, not investment advice and not tailored to your situation.